Eupheria Biotech GmbH is a young, dynamic and fast growing company, which was founded in 2010 as a spin-off of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, introducing highly specific and efficient silencers: esiRNAs!
We were proud, when the Federal Ministry of Education and Research awarded us a GO-Bio Phase II funding in May 2011.
In the meantime, RNA interference screens with esiRNAs have proven to be a very powerful technology to unravel gene function in basic and applied research. The specificity and cost-effectiveness of esiRNAs have revolutionized drug discovery.
Recently, we have developed our esiCRISPR (pronounced "easy CRISPR") product line to provide innovative and effective CRISPR/Cas9 tools for genome engineering.
esiRNA and esiCRISPR, because we are euphoric about phenotypes!